Myth: If the cancer spreads to the bone, there is nothing more we can do.

There are important treatment options for men with metastatic prostate cancer.  If cancer spreads to the bone, it can be painful and aggravate a patient’s condition. New generation hormonal treatments, chemotherapy, radiotherapy, as well as other bone reinforcing medications, offer patients new options that increase their overall survival rate and their quality of life.

Myth: Bone metastasis symptoms cannot be treated.

A number of recent advancements have been made in the treatment of metastatic prostate cancer. It is now possible to reduce the symptoms associated with metastasis. Bisphosphonates and RANK-ligand inhibitors can help reinforce a patient’s bone structure, to avoid fractures or intense pain. Localized radiation therapy can directly target metastases and increase the patient’s comfort.

Myth: It is certain that my son will have prostate cancer because it is hereditary.

If you have prostate cancer, it is possible that your son could be at risk. Heredity is one of many risk factors. Socio-economic factors, including eating habits and even geographic location, can also have an impact. It is recommended that men age 45 and older have a prostate specific antigen (PSA) test if risk factors exist.